<DOC>
	<DOCNO>NCT02737670</DOCNO>
	<brief_summary>The objective prospective randomize double blind control study evaluate efficacy safety Sulodexide ( 25 mg ) treatment chronic idiopathic subjective tinnitus .</brief_summary>
	<brief_title>Sulodexide Efficacy Chronic Idiopathic Subjective Tinnitus</brief_title>
	<detailed_description>Patients chronic idiopathic subjective tinnitus , since least 1 year , recruit Ear , Nose Throat ( ENT ) clinic . After verification inclusion exclusion criterion , patient consent enter study assign randomly one follow group : 1- Sulodexide 25 mg 40 day 2- Placebo 40 day . Clinical evaluation patient perform ; tinnitus assess accord Tinnitus Handicap Inventory score , Mini Tinnitus Questionnaire score , combination score . Adverse effect also note . Patients follow 40 day post-treatment outcome measure assess .</detailed_description>
	<mesh_term>Tinnitus</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>Tinnitus minimum 1 year Absence psychiatric neurological disease Absence disease explain tinnitus Noiseinduced hearing loss Cochlear retrocochlear damage Conductive hearing loss Mixed hearing loss Meniere 's disease Systemic vascular disease Diabetic disease Vestibular schwannoma Cerebellopontine angle tumor Pulsatile tinnitus Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>